€20 million EIB financing to combat biological threats
The European Investment Bank (EIB) and the French biopharmaceutical company Fabentech have signed a €20 million loan to accelerate the development of broad-spectrum therapeutics to combat biological threats to public health. The deal is supported by the Health Emergency Preparedness and Response Authority (HERA), set up… Read More